Europe top stories - weekly summary

03 September 2012 09:00  [Source: ICIS news]

LONDON (ICIS)--Here are some of the top stories from ICIS Europe for the week ended 31 August 2012.

Europe PE/PP producers target sharp September hikes
European polyethylene (PE) and polypropylene (PP) buyers are being faced with sharp September price rises following increases in the ethylene and propylene contracts and producers' intentions to improve margins, several said on Friday.

Outlook is bleak for Europe naphtha market
Despite hopes of increased demand for European naphtha, the physical market is weak and lengthening, sources said on Thursday.

Belgium's Tessenderlo swings to Q2 loss on divestment charges
Tessenderlo swung to a loss of €15.1m ($18.9m) in the second quarter of 2012 compared with a profit of €22.4m in the corresponding period last year, primarily on the back of non-recurring charges of €35.9m, the Belgium-based chemicals firm said on Wednesday.

PolymerLatex acquisition helps lift UK Yule Catto's H1 profits
Yule Catto & Co’s profit in the first half of 2012 rose by 3.9% year on year to £42.6m (€53.9m, $67.6m), as the company’s acquisition of Germany-based emulsion polymer producer PolymerLatex helped to lift its business in Europe, the UK specialty chemicals company said on Tuesday.

ZAP seeks 'merger of equals' with Polish chemicals peer ZAT
The management of Zaklady Azotowe Pulawy (ZAP) is opposed to the proposal that fellow Polish chemical group Zaklady Azoty Tarnow (ZAT) should take ZAP over and is instead supporting efforts to combine the producers in a “merger of equals”, it said on Monday.

(Please click on the links to read the full text)

By: Staff Reporter
+44 20 8652 3214

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly